Kelly Partners Group Holdings Ltd (KPG)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 4.250 |
|---|---|
| 52-week range | 3.350 – 10.440 |
| Return, 1 month / 3 months | −12.0% / +7.6% |
| Return, 1 year / 3 years | −57.6% / +0.3% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 55.6% |
| Worst drawdown (1 year) | -67.3% |
| Average daily value traded | 0.26M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kelly Partners Group is an Australian accounting and advisory firm that serves small and medium-sized businesses and their owners. Its accountants provide tax compliance and planning, audit and assurance, bookkeeping, and business advisory services, along with wealth and financial planning support for clients. The firm is based in Sydney and operates through a partnership model in which accounting practices join the group while keeping local client relationships and day-to-day operations.
The shares are listed on the Australian Securities Exchange in Australia under the code KPG, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kelly Partners Group Holdings Ltd (KPG) trades on the Australian Securities Exchange in Australia. It last closed at AUD 4.250 on 20 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 894 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 57.6% and over the last three months it rose 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.6% | ||
| From 52-week high | -59.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.6% | ||
| 6-month return | -3.2% | ||
| 12-month return, skipping the last month | -51.8% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -67.3% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.26M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | −12.0% |
| 3 months | +7.6% |
| 6 months | −3.2% |
| 1 year | −57.6% |
| 3 years | +0.3% |
| 5 years | +23.9% |
Signals
| 50-day / 200-day average | 4.498 / 4.863 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.216 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Feb 2024 | AUD 0.0044 |
| 19 Jan 2024 | AUD 0.0044 |
| 19 Dec 2023 | AUD 0.0044 |
| 21 Nov 2023 | AUD 0.0044 |
| 20 Oct 2023 | AUD 0.0044 |
| 20 Sep 2023 | AUD 0.0044 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.